title: Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinoma.
authors.affiliation: Department of Medicine, Jonsson Comprehensive Cancer Center, UCLA School of Medicine 90024.
authors.forename: R A
authors.initials: RA
authors.lastname: Figlin
authors.forename: W C
authors.initials: WC
authors.lastname: Pierce
authors.forename: A
authors.initials: A
authors.lastname: Belldegrun
mesh_terms: D000553:Ambulatory Care; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000628:therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007370:Interferon Type I / Q000008:administration & dosage / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000502:physiology; D007376:Interleukin-2 / Q000008:administration & dosage / Q000502:physiology / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000628:therapy*; D015979:Killer Cells, Lymphokine-Activated; D016246:Lymphocytes, Tumor-Infiltrating; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D007370:Interferon Type I; D016898:Interferon-alpha; D007376:Interleukin-2; D011994:Recombinant Proteins